» Articles » PMID: 11815461

Beta-cell Protein Kinases and the Dynamics of the Insulin Response to Glucose

Overview
Journal Diabetes
Specialty Endocrinology
Date 2002 Jan 30
PMID 11815461
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

A full biphasic insulin response is the most sensitive index for well-coupled beta-cell signal transduction. While first-phase insulin response is extremely sensitive to potentiating and inhibiting modulations, full expression of second-phase response requires near maximally activated beta-cell fuel metabolism. In the isolated rat pancreas, accelerated calcium entry or activation of protein kinase (PK)-A or PKC result in no insulin response in the absence of fuel metabolism. At submaximal levels of beta-cell fuel secretagogue, arginine (which promotes calcium entry) or glucagon (which activates PKA) produces a small first-phase insulin response but minimal or no second-phase response; carbachol (which activates PKC and promotes calcium entry) generates biphasic insulin response in the presence of minimal fuel (3.3 mmol/l glucose). Glucagon produces full biphasic response in the presence of 10.0 mmol/l glucose, whereas arginine requires near-maximal stimulatory glucose (16.7 mmol) to produce full biphasic insulin response. Thus, PKA and PKC signal pathways potentiate primary signals generated by fuel secretagogues to induce full biphasic insulin response, while calcium recruitment alone is insufficient to potentiate primary signals generated at low levels of fuel secretagogue. We suggest that three families of PKs (calmodulin-dependent PK [CaMK], PKA, and PKC) function as distal amplifiers for stimulus-secretion coupling signals originating from fuel metabolism, as well as from incretins acting through membrane receptors, adenylate cyclase, and phospholipase C. Several isoenzymes of PKA and PKC are present in pancreatic beta-cells, but the specific function of most is still undefined. Each PK isoenzyme is activated and subsequently phosphorylates its specific effector protein by binding to a highly specific anchoring protein. Some diabetes-related beta-cell derangements may be linked to abnormal function of one or more PK isoenzymes. Identification and characterization of the specific function of the individual PK isoenzymes may provide the tool to improve the insulin response of the diabetic patient.

Citing Articles

A Review of Antidiabetic Medicinal Plants as a Novel Source of Phosphodiesterase Inhibitors: Future Perspective of New Challenges Against Diabetes Mellitus.

Ouassou H, Daoudi N, Bouknana S, Abdnim R, Bnouham M Med Chem. 2024; 20(5):467-486.

PMID: 38265379 DOI: 10.2174/0115734064255060231116192839.


Checkpoint kinase 2 controls insulin secretion and glucose homeostasis.

Chong A, Vandana J, Jeng G, Li G, Meng Z, Duan X Nat Chem Biol. 2023; 20(5):566-576.

PMID: 37945898 PMC: 11062908. DOI: 10.1038/s41589-023-01466-4.


Alpha4 contributes to the dysfunction of the pancreatic beta cell under metabolic stress.

Hali M, Wadzinski B, Kowluru A Mol Cell Endocrinol. 2022; 557:111754.

PMID: 35987388 PMC: 9620510. DOI: 10.1016/j.mce.2022.111754.


Protein kinase C-θ knockout decreases serum IL-10 levels and inhibits insulin secretion from islet β cells.

Hong F, Yang Y, Chen B, Li P, Wang G, Jiang Y Islets. 2021; 13(1-2):24-31.

PMID: 33719858 PMC: 8018435. DOI: 10.1080/19382014.2021.1890963.


Innate Immunity Mediated Inflammation and Beta Cell Function: Neighbors or Enemies?.

Citro A, Campo F, Dugnani E, Piemonti L Front Endocrinol (Lausanne). 2021; 11:606332.

PMID: 33628197 PMC: 7897669. DOI: 10.3389/fendo.2020.606332.